Prohibition Partners

Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

151

6 regions36 stories14 countries

← №150All issues152

Europe

6 stories
  • The Netherlands to begin accepting cultivation applications from next month

    NLRegulationlink no longer available

  • French cannabis startup raises US$1.13 million to launch two new brands

    FRBusiness & Investmentlink no longer available

  • The Netherlands appears to be limiting exports to German wholesalers

    NLDERegulationlink no longer available

  • Deadline to apply for German cannabis distribution contract extended for a third time

    DERegulationlink no longer available

  • Calls for cannabis legalisation in Spain as post-COVID recession nears

    ESRegulationlink no longer available

  • First Irish-based cannabis fund launches in Dublin

    IEBusiness & Investmentlink no longer available

United States

5 stories
  • Columbia Care sued for US$50 million over alleged fraudulent licensing scheme

    USBusiness & Investmentlink no longer available

  • Iowa Senate passes controversial medical cannabis bill reducing allowable THC content

    USMedicallink no longer available

  • Acreage Holdings pulls out of Iowa medical cannabis market

    USBusiness & Investmentlink no longer available

  • Nebraska cannabis legalisation campaign delivers nearly 50,000 petition signatures

    USAdult-uselink no longer available

  • Multiplatinum artist Kelis to present at Prohibition Partners LIVE

    Events & Industrylink no longer available

Canada

5 stories
  • Canadian businesses exported a record amount of dried cannabis in 2019

    CABusiness & Investmentlink no longer available

  • Organigram enters 3,000-kilo cannabis supply agreement with Israeli firm Canndoc

    CABusiness & Investmentlink no longer available

  • New lawsuit alleges Tilray execs misled investors and engaged in insider stock sales

    CABusiness & Investmentlink no longer available

  • Labelling errors see Alberta issue Canada's first cannabis beverage recall

    CARegulationlink no longer available

  • Bonify resumes selling cannabis in Canada after licence suspension

    CABusiness & Investmentlink no longer available

LATAM & Caribbean

4 stories
  • Bermuda seeks public feedback on cannabis legalisation proposal

    BMRegulationlink no longer available

  • Work begins on Peru's first medicinal cannabis pharmacy chain

    PEMedicallink no longer available

  • Cannabis could tackle economic recession in Latin America, says Uruguayan professor

    UYBusiness & Investmentlink no longer available

  • Uruguay plans to become world's largest exporter of medical cannabis in 2020

    UYBusiness & Investmentlink no longer available

Africa & Middle East

4 stories
  • Israeli government announces plan to advance cannabis legalisation reforms

    ILRegulationlink no longer available

  • Malawian firms await implementation of new cannabis farming laws

    MWRegulationlink no longer available

  • Wuhan General Group signs distribution agreement with Medigrow Africa

    Business & Investmentlink no longer available

  • Panaxia Israel announces receipt of EU-GMP certification, advancing EU export

    ILBusiness & Investmentlink no longer available

Oceania

4 stories
  • NSW data shows indigenous people disproportionately prosecuted for cannabis

    AURegulationlink no longer available

  • NZ advertising authority receives complaints over Drug Foundations' referendum adverts

    NZRegulationlink no longer available

  • Auckland University of Technology will offer a course on medicinal cannabis from July

    NZMedicallink no longer available

  • Medical cannabis firm Equalis endorses voting 'no' in upcoming cannabis referendum

    NZMedicallink no longer available

Health & Science

  • Study concludes inaccuracies in CBD product labelling appear to be the norm

    Hemp & CBDlink no longer available

  • No evidence cannabis legalisation impacts adolescent use, finds study

    Health & Sciencelink no longer available

  • CBD shows potential in treating psychiatric and neurologic conditions

    Health & Sciencelink no longer available

Psychedelics

  • Potential of psychedelics in treating depression cannot be ignored, says professor

    Psychedelicslink no longer available

  • Terminally ill Canadians appeal to health minister for compassionate psilocybin use

    CAPsychedelicslink no longer available

  • Numinus amends Health Canada licence to produce and extract psilocybin

    CAPsychedelicslink no longer available

  • Mydecine Innovations Group to acquire NeuroPharm Inc

    Business & Investmentlink no longer available

  • Cambridge scientists identify brain phenomena that may explain ketamine side effects

    Health & Sciencelink no longer available

Never miss an issue

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265

View report